-4-
more
medical practitioners work more efficiently so they can provide quality care more
effectively. These solutions also support
dental laboratories, government and institutional health care clinics, as well
as other alternate care sites.
Henry Schein operates through a centralized and automated distribution
network, with a selection of more than
300,000 branded products and Henry Schein corporate brand products
in our main distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville,
N.Y.,
and has operations or affiliates in 33 countries and territories. The Company's sales reached
$12.7 billion in 2024, and
have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public
company in 1995.
For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein,
Instagram.com/HenrySchein,
and @HenrySchein on X.
Cautionary Note Regarding Forward-Looking Statements and Use
of Non-GAAP Financial Information
In accordance with the “Safe Harbor” provisions of the Private Securities Litigation
Reform Act of 1995, we provide the following
cautionary remarks regarding important factors that, among others,
could cause future results to differ materially from the forward-
looking statements, expectations and assumptions expressed or implied herein.
All forward-looking statements made by us are subject to
risks and uncertainties and are not guarantees of future performance.
These forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause our actual results, performance
and achievements or industry results to be materially
different from any future results, performance
or achievements expressed or implied by such forward-looking
statements.
These statements include total sales growth, EPS and Adjusted EBITDA guidance
and are generally identified by the use of such
terms as “may,” “could,”
“expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,”
“to be,” “to make” or other
comparable terms. A fuller discussion of our operations, financial condition
and status of litigation matters, including factors that may
affect our business and future prospects, is contained
in documents we have filed with the United States Securities and Exchange
Commission, or SEC, including our Annual Report on Form 10-K,
and will be contained in all subsequent periodic filings we make with
the SEC. These documents identify in detail important risk factors that could
cause our actual performance to differ materially from
current expectations.
Risk factors and uncertainties that could cause actual results to differ
materially from current and historical results include, but
are not limited to: our dependence on third parties for the manufacture and
supply of our products and where we manufacture products,
our dependence on third parties for raw materials or purchased components;
risks relating to the achievement of our strategic growth
objectives; risks related to the Strategic Partnership Agreement with KKR Hawaii
Aggregator L.P.
entered into in January 2025; our
ability to develop or acquire and maintain and protect new products (particularly
technology products) and services and utilize new
technologies that achieve market acceptance with acceptable margins;
transitional challenges associated with acquisitions, dispositions
and joint ventures, including the failure to achieve anticipated synergies/benefits,
as well as significant demands on our operations,
information systems, legal, regulatory,
compliance, financial and human resources functions in connection with
acquisitions, dispositions
and joint ventures; certain provisions in our governing documents that may
discourage third-party acquisitions of us; adverse changes in
supplier rebates or other purchasing incentives; risks related to the sale of corporate
brand products; risks related to activist investors;
security risks associated with our information systems and technology products and
services, such as cyberattacks or other privacy or data
security breaches (including the October 2023 incident); effects
of a highly competitive (including, without limitation, competition
from
third-party online commerce sites) and consolidating market; changes
in the health care industry; risks from expansion of customer
purchasing power and multi-tiered costing structures; increases in shipping
costs for our products or other service issues with our third-
party shippers, and increases in fuel and energy costs; changes in laws and
policies governing manufacturing, development and
investment in territories and countries where we do business; general global
and domestic macro-economic and political conditions,
including inflation, deflation, recession, unemployment (and
corresponding increase in under-insured populations),
consumer confidence,
sovereign debt levels, ongoing wars, fluctuations in energy pricing
and the value of the U.S. dollar as compared to foreign currencies,
changes to other economic indicators and international trade agreements;
the threat or outbreak of war, terrorism or public unrest
(including, without limitation, the war in Ukraine, the Israel-Gaza war and
other unrest and threats in the Middle East and the possibility
of a wider European or global conflict); changes to laws and policies governing
foreign trade, tariffs and sanctions, including the current
imposition of additional new tariffs by the U.S. on numerous countries,
retaliatory tariffs and potential for additional retaliatory
tariffs;
greater restrictions on imports and exports; supply chain disruption;
geopolitical wars; failure to comply with existing and future
regulatory requirements, including relating to health care; risks associated
with the EU Medical Device Regulation; failure to comply with
laws and regulations relating to health care fraud or other laws and regulations; failure
to comply with laws and regulations relating to the
collection, storage and processing of sensitive personal information or
standards in electronic health records or transmissions; changes in
tax legislation, changes in tax rates and availability of certain tax deductions; risks
related to product liability,
intellectual property and
